Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAdvanced Medical Solutions Group Regulatory News (AMS)

Share Price Information for Advanced Medical Solutions Group (AMS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 211.00
Bid: 211.00
Ask: 212.50
Change: -1.00 (-0.47%)
Spread: 1.50 (0.711%)
Open: 207.00
High: 212.50
Low: 207.00
Prev. Close: 212.00
AMS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

12 Jun 2012 12:15

RNS Number : 1969F
Advanced Medical Solutions Grp PLC
12 June 2012
 



For immediate release: 12 June 2012

 

Advanced Medical Solutions Group plc 

("AMS")

 

Result of Annual General Meeting

 

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the global medical technology company, held its Annual General Meeting today, at which all resolutions put to shareholders were duly passed.

 

Chris Meredith, AMS's Chief Executive Officer, gave a presentation at the AGM, the slides from which will be made available on the Company's website www.admedsol.com.

 

-ends -

 

For further information, please visit www.admedsol.com or contact:

 

Advanced Medical Solutions Group plc

Tel: +44 (0) 1606 545508

Chris Meredith, Chief Executive Officer

Mary Tavener, Group Finance Director

Tavistock Communications

Tel: +44 (0) 20 7920 3150

John West / Chris Munden / Andrew Dunn

Investec Bank plc

Tel: +44 (0) 20 7597 5970

Gary Clarence / Daniel Adams / Patrick Robb

 

About Advanced Medical Solutions Group plc - see www.admedsol.com 

 

Founded in 1991, AMS is a leader in the development and manufacture of innovative and technologically advanced products for the US$15 billion global wound care market. These products are sold in countries across the globe either directly or through strategic partners and distributors.

 

AMS's advanced woundcare products are based on an extensive range of technologies including alginates, silver alginates and hydrophilic polyurethane foams. These and other products pioneer the concept of moist wound healing, allowing wounds to heal faster and with less pain and scarring. They protect the wound, deal with tissue fluids, provide an optimal environment for healing to occur and, in the case of silver alginates, include a safe and effective broad-spectrum anti-microbial agent for infection control. AMS's advanced woundcare products are sold globally on an Original Equipment Manufacturer basis and, in the UK, direct to the NHS under the ActivHeal® brand.

 

AMS's wound closure and sealants products are based on cyanoacrylate adhesive ("superglue") technology developed for medical applications. Tissue adhesives offer significant benefits over conventional ways of closing wounds following trauma or surgical incision. They are simple to use, non-invasive, help to reduce the risk of infection, minimise trauma to the patient and provide good clinical and cosmetic outcomes. The technology is also ideally suited to protecting skin from breakdown or for use as a skin sealant to help prevent infection of surgical sites. AMS's wound closure and sealants products are primarily sold under the LiquiBand® brand via a network of distributors.

 

In December 2011, AMS acquired RESORBA, a German based woundcare and wound closure business. RESORBA is a 75 year old manufacturer and distributor of sutures and collagen products for surgical disciplines, with direct sales capabilities from sites in Germany, the Czech Republic and Russia, targeting surgeons working in hospitals and private practices, and oral surgery. RESORBA has a range of its own technologies and brands, and also distributes a range of complementary, third-party products, including AMS's LiquiBand® tissue adhesive, which it has distributed in Germany for the previous eight years.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGSFDFFEFESEFM
Date   Source Headline
1st Mar 20107:00 amRNSRule 2.10 Announcement
26th Feb 20102:51 pmRNSPossible Offer
26th Feb 201011:16 amRNSStatement re Possible Offer
11th Feb 20107:00 amRNSNotice of Results
1st Feb 20105:21 pmRNSTotal Voting Rights
28th Jan 20107:00 amRNSLiquiBand US Marketing Deal
19th Jan 20107:00 amRNSAppointment of COO
19th Jan 20107:00 amRNSSite Visit
7th Jan 20107:00 amRNSChange of Registered Office
5th Jan 20104:55 pmRNSHolding(s) in Company
5th Jan 20101:07 pmRNSHolding(s) in Company
5th Jan 20108:59 amRNSHolding(s) in Company
23rd Dec 20095:27 pmRNSHolding(s) in Company
17th Dec 20097:00 amRNSTrading Update
9th Dec 20097:00 amRNSActivHeal? Cuts Costs
30th Oct 200910:37 amRNSHolding(s) in Company
26th Oct 20097:00 amRNSSystagenix Product Launch
16th Oct 20094:03 pmRNSInitial LiquiBandT product introduced to US market
1st Oct 20097:00 amRNSAcquisition of Corpura
29th Sep 200912:01 pmRNSHoldings in Company
11th Sep 20095:36 pmRNSHolding(s) in Company
8th Sep 20097:00 amRNSInterim Results
10th Aug 20099:20 amRNS510(k) Approval for Silver Polyurethane
3rd Aug 20097:00 amRNSNotice of Interim Results
24th Jul 20094:16 pmRNSHolding(s) in Company
9th Jul 20097:00 amRNSLiquiband deal with Stryker
6th Jul 20094:22 pmRNSHolding(s) in Company
29th Jun 20099:37 amRNSHolding(s) in Company
10th Jun 20097:00 amRNSDirector Share Purchases
5th Jun 20097:00 amRNSGrowth Company Investor Show
3rd Jun 20092:36 pmRNSResult of AGM
3rd Jun 20097:00 amRNSAGM Statement
28th May 20095:36 pmRNSHolding(s) in Company
27th May 20097:00 amRNSInteguSeal reduces SSIs
22nd May 200911:14 amRNSPosting of Annual Report
30th Apr 20093:09 pmRNSBlocklisting Six Monthly Return
30th Apr 20093:04 pmRNSTotal Voting Rights
30th Apr 20093:01 pmRNSAdditional Listing
24th Apr 20097:00 amRNSDirector shareholdings
20th Apr 20094:42 pmRNSHolding(s) in Company
9th Apr 20094:01 pmRNSExceptional non-trading items
7th Apr 20099:43 amRNSDirector/PDMR Shareholding - Replacement
3rd Apr 20095:36 pmRNSHolding(s) in Company
3rd Apr 20093:57 pmRNSDirector/PDMR Shareholding
30th Mar 20093:43 pmRNSHolding(s) in Company
25th Mar 20099:00 amRNSHolding(s) in Company
17th Mar 20097:00 amRNSPreliminary Results
13th Mar 20094:52 pmRNSNomad and Broker Appointment
4th Mar 20097:00 amRNSNotice of Results
18th Feb 20099:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.